Immunology and genetics of type 1 diabetes
dc.contributor.author | Morran, Michael P. | en_US |
dc.contributor.author | Omenn, Gilbert S. | en_US |
dc.contributor.author | Pietropaolo, Massimo | en_US |
dc.date.accessioned | 2008-10-01T15:24:02Z | |
dc.date.available | 2009-09-02T14:40:29Z | en_US |
dc.date.issued | 2008-08 | en_US |
dc.identifier.citation | Morran, Michael P.; Omenn, Gilbert S.; Pietropaolo, Massimo (2008). "Immunology and genetics of type 1 diabetes." Mount Sinai Journal of Medicine 75(4): 314-327. <http://hdl.handle.net/2027.42/60987> | en_US |
dc.identifier.issn | 0027-2507 | en_US |
dc.identifier.issn | 1931-7581 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/60987 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18729178&dopt=citation | en_US |
dc.description.abstract | Type 1 diabetes is one of the most well-characterized autoimmune diseases. Type 1 diabetes compromises an individual's insulin production through the autoimmune destruction of pancreatic Β-cells. Although much is understood about the mechanisms of this disease, multiple potential contributing factors are thought to play distinct parts in triggering type 1 diabetes. The immunological diagnosis of type 1 diabetes relies primarily on the detection of autoantibodies against islet antigens in the serum of type 1 diabetes mellitus patients. Genetic analyses of type 1 diabetes have linked human leukocyte antigen, specifically class II alleles, to susceptibility to disease onset. Environmental catalysts include various possible factors, such as viral infections, although the evidence linking infections with type 1 diabetes remains inconclusive. Imbalances within the immune system's system of checks and balances may promote immune activation, while undermining immune regulation. A lack of proper regulation and overactive pathogenic responses provide a framework for the development of autoimmune abnormalities. Type 1 diabetes is a predictable and potentially treatable disease that still requires much research to fully understand and pinpoint the exact triggering events leading to autoimmune activation. In silico research can aid the comprehension of the etiology of complex disease pathways, including Type I diabetes, in order to and help predict the outcome of therapeutic strategies aimed at preserving Β-cell function. Mt Sinai J Med 75:314–327, 2008. © 2008 Mount Sinai School of Medicine | en_US |
dc.format.extent | 177896 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Medicine and Healthcare | en_US |
dc.subject.other | Public Health | en_US |
dc.title | Immunology and genetics of type 1 diabetes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Laboratory of Immunogenetics, Brehm Center for Type 1 Diabetes Research and Analysis, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Center for Computational Medicine and Biology, Departments of Internal Medicine and Human Genetics, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Laboratory of Immunogenetics, Brehm Center for Type 1 Diabetes Research and Analysis, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI ; Laboratory of Immunogenetics Brehm Center for Type 1 Diabetes Research and Analysis Ann Arbor, MI | en_US |
dc.identifier.pmid | 18729178 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/60987/1/20052_ftp.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1002/msj.20052 | en_US |
dc.identifier.source | Mount Sinai Journal of Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.